Study of AT673 plus semaglutide for type 2 diabetes and weight loss
Part of Hormones & metabolism clinical trials.
This study tests a new medication called AT673 combined with semaglutide (Wegovy) to help people with type 2 diabetes and overweight or obesity lose weight and improve blood sugar. It is for people who have tried diet and exercise to lose weight but haven't had success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with type 2 diabetes.
- Your BMI is 27 or higher (overweight or obese).
- Your blood sugar control (HbA1c) is between 7% and 10%.
- You have had diabetes for at least 6 months.
- You are not taking insulin or certain other diabetes medications (like Ozempic or Mounjaro) in the past 6 months.
- You have not had weight loss surgery in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a weekly injection of semaglutide (the same drug in Wegovy and Ozempic) can help people with atrial fibrillation lose weight and improve their heart condition. It's for people with AF who also have obesity, and may or may not plan to have a heart procedure called catheter ablation.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests a small implant placed under the skin that slowly releases semaglutide, a medication that helps with weight management. It's for people who are overweight but do not have diabetes.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Adults With Overweight/Obesity and Type 2 Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.